CEACAM5 and colorectal carcinoma: A comparative study of the affinity enhancement system (AES) with a murine anti-CEA × anti-DTPA-In bsAb and conventional RIT in a LS174T human CRC animal model demonstrated the superiority of pretargeting [44].